131 related articles for article (PubMed ID: 24870876)
1. Lenalidomide in combination with R-CHOP (R2-CHOP) in patients with high burden follicular lymphoma: phase 2 study.
Clin Adv Hematol Oncol; 2014 Feb; 12(2 Suppl 6):12; 14-5. PubMed ID: 24870876
[No Abstract] [Full Text] [Related]
2. Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.
Nowakowski GS; LaPlant B; Habermann TM; Rivera CE; Macon WR; Inwards DJ; Micallef IN; Johnston PB; Porrata LF; Ansell SM; Klebig RR; Reeder CB; Witzig TE
Leukemia; 2011 Dec; 25(12):1877-81. PubMed ID: 21720383
[TBL] [Abstract][Full Text] [Related]
3. Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study.
Tilly H; Morschhauser F; Casasnovas O; Molina TJ; Feugier P; Gouill SL; Haioun C; Tournilhac O; Bouabdallah R; Gabarre J; Lamy T; Cabeçadas J; Becker S; Jardin F; Mounier N; Salles G;
Lancet Haematol; 2018 Sep; 5(9):e403-e410. PubMed ID: 30172345
[TBL] [Abstract][Full Text] [Related]
4. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma.
Clin Adv Hematol Oncol; 2006 Jul; 4(7):536-8. PubMed ID: 17147240
[No Abstract] [Full Text] [Related]
5. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?
Gordon LI
Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340
[No Abstract] [Full Text] [Related]
6. Retrospective study of the utility of FLIPI/FLIPI-2 for follicular lymphoma patients treated with R-CHOP.
Numata A; Tomita N; Fujimaki K; Tanaka M; Hashimoto C; Oshima R; Matsumoto K; Matsuura S; Yamamoto W; Motomura S; Ishigatsubo Y
J Clin Exp Hematop; 2012; 52(1):77-9. PubMed ID: 22706536
[No Abstract] [Full Text] [Related]
7. High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy.
Kusano Y; Yokoyama M; Terui Y; Inoue N; Takahashi A; Yamauchi H; Tsuyama N; Nishimura N; Mishima Y; Takeuchi K; Hatake K
Blood Cancer J; 2017 Sep; 7(9):e614. PubMed ID: 28960192
[No Abstract] [Full Text] [Related]
8. Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma.
Chan TS; Khong PL; Kwong YL
Ann Hematol; 2016 Oct; 95(11):1917-8. PubMed ID: 27473194
[No Abstract] [Full Text] [Related]
9. Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.
Derenzini E; Casadei B; Broccoli A; Gandolfi L; Pellegrini C; Zinzani PL
Br J Haematol; 2014 Aug; 166(4):625-8. PubMed ID: 24750128
[No Abstract] [Full Text] [Related]
10. [Follicular lymphoma].
Tomita N
Nihon Rinsho; 2014 Mar; 72(3):488-92. PubMed ID: 24724409
[TBL] [Abstract][Full Text] [Related]
11. Relative dose intensity of R-CHOP therapy and patient outcomes in advanced follicular lymphoma.
Konishi T; Kanemasa Y; Sasaki Y; Okuya T; Yamaguchi T; Funasaka C; Shimoyama T; Omuro Y
Hematol Oncol; 2019 Aug; 37(3):303-307. PubMed ID: 30933366
[No Abstract] [Full Text] [Related]
12. CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial.
Jäger G; Quehenberger F; Linkesch W; Neumeister P
Eur J Haematol; 2007 May; 78(5):453-5. PubMed ID: 17419745
[No Abstract] [Full Text] [Related]
13. ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma.
Nowakowski GS; Chiappella A; Witzig TE; Spina M; Gascoyne RD; Zhang L; Flament J; Repici J; Vitolo U
Future Oncol; 2016 Jul; 12(13):1553-63. PubMed ID: 27089170
[TBL] [Abstract][Full Text] [Related]
14. [Comparison between CHOP-like and R-CHOP in diffuse large B cell and follicular lymphoma].
Oliver C; Guillermo C; Martínez P; Díaz L
Rev Med Chil; 2013 Jul; 141(7):844-52. PubMed ID: 24356732
[TBL] [Abstract][Full Text] [Related]
15. [Systemic follicular lymphoma with cutaneous manifestations and exclusively cutaneous recurrence].
Palacios Abufón A; Acebo Mariñas E; Gardeazabal García J; García-Ruiz JC
Actas Dermosifiliogr; 2012 Apr; 103(3):253-5. PubMed ID: 22093542
[No Abstract] [Full Text] [Related]
16. A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Hutchison-Rzepka A; Tighiouart M; Heffner LT; Lechowicz MJ; Lonial S; Flowers CR
Cancer; 2012 Jul; 118(14):3538-48. PubMed ID: 22535574
[TBL] [Abstract][Full Text] [Related]
17. R-CHOP therapy alone for limited-stage follicular lymphoma.
Tomita N; Suzuki T; Ishiyama Y; Miyashita K; Takahashi H; Numata A; Ito S; Motohashi K; Tachibana T; Takasaki H; Kawasaki R; Hagihara M; Hashimoto C; Yamazaki E; Taguchi J; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
Leuk Res; 2015 Jun; 39(6):582-5. PubMed ID: 25866096
[TBL] [Abstract][Full Text] [Related]
18. High-dose therapy for follicular lymphoma revisited: not if, but when?
Lister TA
J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
[No Abstract] [Full Text] [Related]
19. R2-CHOP vs R-CHOP for diffuse large B-cell lymphoma.
Fowler NH
Clin Adv Hematol Oncol; 2014 Sep; 12(9):608-10. PubMed ID: 25654483
[No Abstract] [Full Text] [Related]
20. Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma.
McClanahan F; Hielscher T; Rieger M; Hensel M; Bentz M; Schmidt-Wolf I; Käbisch A; Salwender H; Dürk H; Staiger H; Mandel T; Neben K; Hillengass J; Leo E; Krämer A; Ho AD; Witzens-Harig M
Am J Hematol; 2012 Oct; 87(10):E68-71. PubMed ID: 22847344
[No Abstract] [Full Text] [Related]
[Next] [New Search]